Clinical Endocannabinoid Deficiency was a theory posited by Dr. Russo back in 2001 in which he theorized that low endocannabinoid levels could be behind a range of chronic conditions such as IBS, fibromyalgia, migraines, and other treatment-resistant syndromes. Dr. Russo suggested that because these conditions are all developed over time, rather than congenitally, and that they could be a result of disturbances to the ECS. This also means there’s a possibility of reversing them.
The transfer of The Hawthorne Collective to a strategic partner was made in exchange for…
A vape cartridge is essentially the most important feature of any vape pen. The cart…
But here's what keeps me up at night: How much research is enough? We currently…
As someone who's watched the cannabis industry evolve from underground operations to licensed businesses with…
The question about marijuana in the Minecraft movie might seem out of place, given the…
Get ready for MARY FEST! New York’s premier cannabis & culture festival kicks off April…